Precision Biomems is a company founded by a neurosurgeon and engineer with a vision to develop high-bandwidth digital connections to the brain without penetrating electrodes. Their core product, the Layer 7 Cortical Interface, is a high-resolution cortical surface array aimed at restoring functions like speech and movement to paralyzed individuals. They are focused on developing safe and minimally invasive brain-computer interfaces for medical applications, with plans to launch their first commercial product in 2025. Precision Biomems is at the forefront of brain-computer interface technology, aiming to make a clinical impact in areas such as stroke rehabilitation and refractory depression.